These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8077869)

  • 1. [Hormone replacement therapy in menopause, hemostasis and thromboembolic risk].
    Levesque H; Cailleux N; Courtois H
    J Mal Vasc; 1994; 19(2):93-7. PubMed ID: 8077869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oral contraception and menopausal hormone replacement: effects on hemostasis and risk of venous thromboembolism].
    Bounameaux H; de Moerloose P; Campana A
    Schweiz Med Wochenschr; 1996 Oct; 126(41):1756-63. PubMed ID: 8966508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of hormone replacement treatment of menopause on the risk of venous thromboembolic disease].
    Thery C; Prat A; Asseman P; Bauchart JJ; Michon P; Lesenne M; Jude B
    Therapie; 1997; 52(3):165-8. PubMed ID: 9366099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estrogen therapy and venous thromboembolic disease].
    Lévesque H; Courtois H
    Rev Med Interne; 1997; 18 Suppl 6():620s-625s. PubMed ID: 9515142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormone therapy and cardiovascular risk].
    Wütschert R; Cirafici P
    Praxis (Bern 1994); 2000 Jun; 89(25-26):1090-7. PubMed ID: 11367591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptive pills and hormonal replacement therapy and thromboembolic disease.
    Mammen EF
    Hematol Oncol Clin North Am; 2000 Oct; 14(5):1045-59, vii-viii. PubMed ID: 11005033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of venous thrombosis with hormone-replacement therapy.
    Vandenbroucke JP; Helmerhorst FM
    Lancet; 1996 Oct; 348(9033):972. PubMed ID: 8855846
    [No Abstract]   [Full Text] [Related]  

  • 8. [The pill and thromboembolism. 1. Thrombogenesis and additional risk factors. A review of the literature].
    Herzog C; Mall-Haefeli M
    Ther Ggw; 1979 Oct; 118(10):1550-74. PubMed ID: 386549
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
    Gomes MP; Deitcher SR
    Arch Intern Med; 2004 Oct; 164(18):1965-76. PubMed ID: 15477430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estrogens and cardiovascular diseases: should current guidelines be changed?].
    Beller F; Theiss W
    Zentralbl Gynakol; 1994; 116(8):441-8. PubMed ID: 7941812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormonal contraceptive agents as a risk factor in the development of acute thromboembolic diseases].
    Lambrekht R; Vageman V; Vinkelman B; Geĭnrikh P
    Khirurgiia (Mosk); 1986 Dec; (12):90-3. PubMed ID: 3821001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk of thromboembolism in contraception and hormone substitution: an update and recommendations].
    van den Brûle F; Gaspard U
    J Pharm Belg; 2004; 59(1):38-40. PubMed ID: 15129579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical strategies for hormone replacement therapy and risk of venous thromboembolism.
    Greer IA
    Br J Obstet Gynaecol; 1998 Apr; 105(4):376-9. PubMed ID: 9609259
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of hormonal changes in women on hemostasis].
    Malý J; Dulícek P
    Vnitr Lek; 2002 Dec; 48(12):1169-73. PubMed ID: 12642936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen replacement therapy is not conducive of venous thromboembolism.
    Young RL; Goepfert AR; Goldzieher HW
    Maturitas; 1991 Sep; 13(3):189-92. PubMed ID: 1943826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptives and hormonal replacement therapy cause an imbalance in coagulation and fibrinolysis which may explain the increased risk of venous thromboembolism.
    Levi M; Middeldorp S; Büller HR
    Cardiovasc Res; 1999 Jan; 41(1):21-4. PubMed ID: 10325950
    [No Abstract]   [Full Text] [Related]  

  • 17. Drugs in the peri-operative period: 3--Hormonal contraceptives and hormone replacement therapy.
    Drug Ther Bull; 1999 Oct; 37(10):78-80. PubMed ID: 10696684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormones and pregnancy: thromboembolic risks for women.
    Kujovich JL
    Br J Haematol; 2004 Aug; 126(4):443-54. PubMed ID: 15287937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of estrogen-induced venous thromboembolism.
    Tchaikovski SN; Rosing J
    Thromb Res; 2010 Jul; 126(1):5-11. PubMed ID: 20163835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Estrogen therapy for the climateric and thromboembolic risk].
    Campagnoli C; Prelato L; Rossetti MG
    Minerva Ginecol; 1980 May; 32(5):429-35. PubMed ID: 7393492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.